![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Reports Preliminary Results From Phase 2 Clinical Trial of Surfaxin in Pediatric Acute Respiratory Failure
09 juin 2010 07h30 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., June 9, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Receives FDA Guidance Regarding Preclinical Program to Gain Surfaxin(R) Approval
08 juin 2010 16h10 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., June 8, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announces today that it has received written guidance from the U.S. Food and Drug Administration (FDA) that...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Announces Listing Transfer to NASDAQ Capital Market
02 juin 2010 16h05 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., June 2, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq: DSCO), announced today that The Nasdaq Stock Market, LLC has approved Discovery Labs' application to transfer...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Achieves Key Milestone Towards Potential Surfaxin(R) Approval
19 mai 2010 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 19, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announces today that the revalidation of its optimized fetal rabbit Biological Activity Test (BAT, an...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs' KL4 Surfactant Demonstrates Potential Protective Role for Lung Transplantation in Established Preclinical Model
17 mai 2010 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 17, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced that data from a preclinical study using Discovery Labs' KL4 surfactant (lucinactant) in an...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs' Phase 2a Aerosurf(R) Study Published in Journal of Aerosol Medicine and Pulmonary Drug Delivery
14 mai 2010 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 14, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announces the publication of results from its previously-conducted Phase 2a feasibility study of...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Surfaxin LS(TM) Improves Pulmonary Function and Reduces Lung Inflammation in Established Model of Respiratory Distress Syndrome
05 mai 2010 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 5, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announced that new data regarding Surfaxin LSTM (its novel, lyophilized KL4 surfactant dosage form)...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs' KL4 Surfactant Data to be Presented at Pediatric Academic Societies Annual Meeting and American Thoracic Society International Conference
28 avr. 2010 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 28, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announced that new data supporting the unique properties of its KL4 surfactant technology will be...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Announces Conference Call
28 avr. 2010 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 28, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will be hosting a conference call today, Wednesday, April 28, 2010, at 10:00 AM EDT. Management will...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Provides Updates on Surfaxin(R), Other Key Programs and First Quarter 2010 Financial Results
27 avr. 2010 18h33 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 27, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a biotechnology company developing its novel synthetic surfactant and aerosol technologies for...